Benchsci

Toronto, Canada Founded: 2015 • Age: 11 yrs
AI platform used for extracting antibody data from scientific papers.
Request Access

About Benchsci

Benchsci is a company based in Toronto (Canada) founded in 2015.. Benchsci has raised $157.73 million across 8 funding rounds from investors including Northleaf, Generation Investment Management and Inovia Capital. Benchsci offers products and services including ASCEND. Benchsci operates in a competitive market with competitors including Nona Biosciences, EPITOPIC, Deep Biologics, AB-Pred and NatIgGs, among others.

  • Headquarter Toronto, Canada
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Scinapsis Analytics Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Artificial Intelligence & Machine Learning
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $157.73 M (USD)

    in 8 rounds

  • Latest Funding Round
    $70 M (USD), Series D

    May 25, 2023

  • Investors
    Northleaf

    & 11 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Benchsci

Benchsci offers a comprehensive portfolio of products and services, including ASCEND. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Generative AI tool for analyzing scientific data in pharma R&D

People of Benchsci
Headcount 50-200
Employee Profiles 67
Board Members and Advisors 9
Employee Profiles
People
Joshua Sirota
Senior Software Engineer - Machine Learning Platform
People
Christopher Carmean
Manager, Enterprise Scientific Liaisons
People
Liran Belenzon
Co-Founder & CEO
People
Polly Zhang
Chief Of Staff

Unlock access to complete

Board Members and Advisors
people
Jessica Neal
Technology Advisor
people
Matt Truppo
Science Advisor
people
Scott Oloff
Science Advisor
people
Sylke Poehling
Science Advisor

Unlock access to complete

Funding Insights of Benchsci

Benchsci has successfully raised a total of $157.73M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $70 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Series D — $70.0M
  • First Round
  • Investors Count 12
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2023 Amount Series D - Benchsci Valuation Generation Investment Management
Jan, 2022 Amount Series C - Benchsci Valuation Inovia Capital , TCV
Feb, 2020 Amount Series B - Benchsci Valuation F-Prime Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Benchsci

Benchsci has secured backing from 12 investors, including venture fund investors. Prominent investors backing the company include Northleaf, Generation Investment Management and Inovia Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity firm focused on sustainable investments
Founded Year Domain Location
Investments are made in early-stage technology companies by Inovia Capital.
Founded Year Domain Location
Venture capital is invested in global technology companies by TCV.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Benchsci

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Benchsci

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Benchsci Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Benchsci

Benchsci operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nona Biosciences, EPITOPIC, Deep Biologics, AB-Pred and NatIgGs, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Offers antibody discovery, development, and engineering services for biotherapeutics.
domain founded_year HQ Location
Provider of cell therapy and antibody services
domain founded_year HQ Location
Provider of an AI-based antibody mining and screening platform for R&D work
domain founded_year HQ Location
Provides antibody prediction software for specialized applications.
domain founded_year HQ Location
Biotech startup discovers and improves natural antibodies for brain disease treatments using AI.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Benchsci

Frequently Asked Questions about Benchsci

When was Benchsci founded?

Benchsci was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Where is Benchsci located?

Benchsci is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.

Is Benchsci a funded company?

Benchsci is a funded company, having raised a total of $157.73M across 8 funding rounds to date. The company's 1st funding round was a Series B of $22M, raised on May 01, 2016.

What does Benchsci do?

Founded in 2015 and based in Toronto, Canada, BenchSci operates in the biotechnology sector. An AI-based platform is provided to enable searches across millions of scientific papers for antibody usage evidence. Data is extracted and organized around specific antibodies to support reagent and antibody selection. Biomedical discoveries are facilitated through streamlined experiment design and data management processes.

Who are the top competitors of Benchsci?

Benchsci's top competitors include Deep Biologics, EPITOPIC and Nona Biosciences.

What products or services does Benchsci offer?

Benchsci offers ASCEND.

Who are Benchsci's investors?

Benchsci has 12 investors. Key investors include Northleaf, Generation Investment Management, Inovia Capital, TCV, and F-Prime Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available